Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical stage biotechnology company developing novel biologics designed ...

Gluten might appear harmless, but for some individuals, it can silently provoke significant health problems. Often lacking ...

Chronic inflammation can lead to a number of complications, from fatigue to skin problems and persistent pain, but adding one ...

Caring for the scalp, getting perfumed and enjoying, sending greetings and donating, getting ready for Independence Day, and ...

Researchers at the University Health Network (UHN) and the University of Toronto have developed a skin-based test that can detect signature features of progressive supranuclear palsy (PSP), a rare ...

The U.S. Food and Drug Administration approved Abeona Therapeutics' gene therapy for a rare skin disorder on Tuesday.

The condition, recessive dystrophic epidermolysis bullosa, causes chronic wounds and has an 84% mortality rate by age 40.

Learn more about Malassezia, a type of fungi that's found on human skin, which could help humans fight off ...

With smart dietary choices, one can increase their Omega-3 intake. The food sources are diverse, from fish for pescatarians to great vegan alternatives. ALSO READ: Want to add more omega-3s to your ...

Recent years have seen significant advancements in UC treatment, offering renewed hope for patients seeking effective and ...

Zevaskyn, which Abeona priced at $3.1 million, treats epidermolysis bullosa. It will compete with a gene therapy from Krystal ...

Patients with the debilitating dermatologic condition are born with COL7A1 mutations in both gene copies, affecting the ...